While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

Patients taking these medicines should tell their health professional if they experience new or worsening depression, ...

The Australian Therapeutic Goods Administration (TGA) has updated and aligned safety warnings for people using GLP-1 and dual ...

Australia's TGA has added mental health warnings to Ozempic and other GLP-1 drugs after reports of depression and suicidal ...

Australia’s TGA has issued updated safety warnings for GLP-1 drugs like Ozempic and Mounjaro, highlighting mental-health ...

Australia’s medicines regulator has issued a safety warning over the risk of suicidal thoughts and behaviour linked to drugs ...

Australia’s drug regulator, the Therapeutic Goods Administration (TGA), has added two new safety warnings about mental health ...

FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other diabetes medications in their adverse ...

Ozempic-style medications have been recommended as long-term treatments for obesity under new guidelines released by the ...

Australia's Therapeutic Goods Administration has issued new safety warnings about mental health risks and contraception ...

Australia's GLP-1 boom is accelerating trends reshaping Australia's food landscape, according to a new research.

A first-of-its-kind oral drug boosts muscle metabolism to improve blood sugar and body composition is now headed into larger clinical trials. Lowering blood sugar and increasing fat burning – without ...